Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CLOXACILLIN SODIUM

CLOXACILLIN SODIUM

Standard Dose
EQ 500MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CLOXACILLIN SODIUM is listed in Drugs@FDA under application 062240 (ANDA).

Marketing status: Discontinued Active ingredient CLOXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor TEVA Submission history Latest submission status date: 2000-07-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLOXACILLIN SODIUM is listed in Drugs@FDA under application 062240 (ANDA). Marketing status: Discontinued Active ingredient CLOXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor TEVA Submission history Latest submission status date: 2000-07-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
CLOXACILLIN SODIUM (CLOXACILLIN SODIUM) | Drug Monograph | MedicHelpline